Heartland Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-105,800
Closed -$2.02M 190
2022
Q3
$2.02M Sell
105,800
-455,000
-81% -$10.2M 0.15% 154
2022
Q2
$13.2M Buy
560,800
+100,000
+22% +$2.86M 0.92% 26
2022
Q1
$15.1M Buy
460,800
+103,000
+29% +$3.31M 0.93% 21
2021
Q4
$11.1M Buy
357,800
+124,800
+54% +$4.17M 0.65% 54
2021
Q3
$8.88M Buy
233,000
+108,000
+86% +$4.3M 0.54% 71
2021
Q2
$5.01M Buy
125,000
+25,000
+25% +$1.06M 0.29% 139
2021
Q1
$4.33M Hold
100,000
0.27% 143
2020
Q4
$4.3M Buy
+100,000
New +$3.65M 0.31% 131

Other funds holding OFIX

Heartland Advisors's OFIX Position: Q4 2022 in Review

Heartland Advisors sold out of Orthofix Medical (OFIX) in Q4 2022, closing a stake of 105,800 shares — an estimated $2.02M sold.

Heartland Advisors first reported a position in OFIX in Q4 2020 and held it in 8 quarters. The position peaked at $15.1M in Q1 2022. 153 funds tracked by Wall St. Rank hold OFIX as of Q4 2022.

  • Heartland Advisors reported no remaining Orthofix Medical position as of Q4 2022 after selling out during the quarter.
  • Heartland Advisors sold 105,800 Orthofix Medical shares in Q4 2022, an estimated $2.02M.
  • Heartland Advisors first reported a position in Orthofix Medical in Q4 2020 and held it in 8 quarters.
  • Heartland Advisors's Orthofix Medical position peaked at $15.1M in Q1 2022.
  • 153 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2022.

Based on Heartland Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.